PlainPill

MDMA

The short answer. Most people who report on MDMA say it did not help (only 33% of 37 positive). It is most often used for mood: 59% of 29 reports say that improved. It is well studied — 99 meta-analyses on PubMed. The most common complaint is neurotoxicity.

What users report
33%helped37 reports · medium confidence
12 helped11 mixed14 didn't help

From 82 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
99
meta-analyses
165
RCTs
5,551
papers

What MDMA does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 99 meta-analyses on PubMed ↗ · 165 randomized trials ↗

Eur J Psychotraumatol · 2021 · Meta-analysis / systematic review
Pharmacological therapy for post-traumatic stress disorder: a systematic review and meta-analysis of monotherapy, augmentation and head-to-head approaches

Conclusion: Two medications, prazosin and risperidone, also have a small positive effect when used to augment pharmacological monotherapy. There was no evidence of superiority for one intervention over another in the small number of head-to-head comparison studies.

PubMed 34992738 ↗
BMJ · 2024 · Meta-analysis / systematic review
Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis

Conclusion: Of the available psychedelic treatments for depressive symptoms, patients treated with high dose psilocybin showed better responses than those treated with placebo in the antidepressant trials, but the effect size was small.

PubMed 39168500 ↗
Registered clinical trials

125 human trials on ClinicalTrials.gov test MDMA — 72 completed, 24 recruiting now. See all on ClinicalTrials.gov ↗

What government agencies say

Official records from US, Canadian and EU regulators, each linked to its source.

US legal status (DEA)

MDMA is a Schedule I controlled substance in the US (listed as 3,4-Methylenedioxymethamphetamine). DEA controlled-substance list ↗

US government research funding (NIH)

NIH has funded 97 research projects with MDMA in the title, $79,598,420 in total (1986–2026). NIH RePORTER ↗

Dosage people report

As stated by users — not a recommendation. Follow the label or your doctor.

0.14 gno more than every 1.5-2 months
100-120 mgonce every few months
200 mgonce every 4-5 months
300 mg to 700 mg12-13 high-dose uses plus 7 moderate rolls
0.3-0.8 gevery 5 days

Reported side effects

How often each side effect came up across all reports.

neurotoxicity ×6anxiety ×4fatigue ×3anhedonia ×2overheating ×1withdrawal ×1memory deficits ×1insomnia ×1

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

“I feel that MDMA changed my personality forever, in a good way.”
HelpedRead the discussion ↗
“Probably great for PTSD but it did nothing really for me. I mean great experience but against depressive or anxiety symptoms it doesn't do shit long-term.”
Didn't helpRead the discussion ↗
“I don't feel I ever fully recovered and that's been over 20 years now. I can still remember the lows afterwards like yesterday.”
Didn't helpRead the discussion ↗
“I took my 200mg dose and felt absolutely nothing. The only thing I got out of it was the inability to sleep, and urinate.”
MixedRead the discussion ↗
Read more MDMA reviews →
Top discussions (5)

Other options for mood

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate